Tesla Inc
Change company Symbol lookup
Select an option...
TSLA Tesla Inc
WTR Aqua America Inc
BAC Bank of America Corp
NOK Nokia Oyj
LMAT LeMaitre Vascular Inc
CXW CoreCivic Inc
SITE SiteOne Landscape Supply Inc
CCJ Cameco Corp

Consumer Discretionary : Automobiles | Large Cap GrowthCompany profile

Tesla, Inc., formerly Tesla Motors, Inc., designs, develops, manufactures and sells fully electric vehicles, and energy storage systems, as well as installs, operates and maintains solar and energy storage products. The Company operates through two segments: Automotive, and Energy generation and storage. The Automotive segment includes the design, development, manufacturing, and sales of electric vehicles. The Energy generation and storage segment includes the design, manufacture, installation, and sale or lease of stationary energy storage products and solar energy systems to residential and commercial customers, or sale of electricity generated by its solar energy systems to customers. The Company produces and distributes two fully electric vehicles, the Model S sedan and the Model X sport utility vehicle (SUV). It also offers Model 3, a sedan designed for the mass market. It develops energy storage products for use in homes, commercial facilities and utility sites.


Last Trade
-1.43 (-0.46%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Canopy Growth shares climb premarket as Piper Jaffray raises price target to $60 vs. $40

10:54 am ET January 25, 2019 (MarketWatch)

Piper Jaffray raised its stock price target on Canadian cannabis company Canopy Growth Corp. (WEED.T) late Thursday and said the company is well positioned in the emerging and growing market. Analysts Michael Lavery and Jeffrey Kratky raised their target to $60 from $40 and reiterated their overweight rating on the stock. Piper is expecting the global cannabis market to be worth $250 billion to $500 billion long term and to be worth $15 billion to be $50 billion near term. "We believe the long-term growth can be significant - both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health & wellness categories to CBD-infused products," they wrote in a note. Canopy's recent success in receiving a legal hemp license in New York is "a tangible first step forward in the U.S. that points to the beginning of a long US growth trajectory," said the note. The analysts nonetheless trimmed their estimates for an initial sales build. They are now expecting 10,000 kg sold for Canopy in the Canadian recreational market in its fiscal third quarter, down from 14,000 kg, or for C$87 million ($65.3 million). Canopy's U.S.-listed shares were up 2.2% premarket and have gained 64% in 2019 so far, while the S&P 500 has gained 5.4%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

January 25, 2019 10:54 ET (15:54 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.